Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/21/2005EP1576151A2 Ap1 amine oxidase variants
09/21/2005EP1576150A2 Methods and compositions for increasing the efficacy of biologically-active ingredients
09/21/2005EP1576147A1 Bacterial strains delftia acidovorans mc1-s, production and use thereof for the production of the s enantiomers of 2-phenoxypropionic acid derivatives
09/21/2005EP1576146A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576145A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof
09/21/2005EP1576144A2 Proteorhodopsin mutants with improved optical characteristics
09/21/2005EP1576143A2 Virus-like particles, methods of preparation, and immonogenic compositions
09/21/2005EP1576140A2 Synthetic genes
09/21/2005EP1576128A2 Products and processes for modulating peptide-peptide binding domain interactions
09/21/2005EP1576123A2 Process for the biological production of 1,3-propanediol with high yield
09/21/2005EP1576118A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
09/21/2005EP1576114A2 Compositions and methods for controlling parasitic nematodes
09/21/2005EP1576113A2 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576106A2 Process and materials for production of glucosamine and n-acetylglucosamine
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576096A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
09/21/2005EP1576094A2 Methods of creating modified promoters resulting in varying levels of gene expression
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576089A2 Expansion of renewable stem cell populations
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576087A2 Method for detecting remote homologues and kinases identified with the method
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576014A1 Antibodies against pd-1 and uses therefor
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1576009A2 Novel fibulin-like polypeptides
09/21/2005EP1576007A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
09/21/2005EP1576005A2 Notch-like polypeptides
09/21/2005EP1576003A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
09/21/2005EP1576002A2 Peptide oligomers for use as hiv vaccines
09/21/2005EP1575999A2 Increasing production of proteins in gram-positive microorganisms
09/21/2005EP1575998A2 Mammalian cell culture processes for protein production
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
09/21/2005EP1575987A2 Conjugates of membrane translocating agents and pharmaceutically active agents
09/21/2005EP1575985A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575980A2 Rna interference
09/21/2005EP1575977A2 Immunostimulatory sequence oligonucleotides and methods of using the same
09/21/2005EP1575976A2 Methods and compositions for therapeutic use of rna interference
09/21/2005EP1575917A2 Hemipteran muscarinic receptor
09/21/2005EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
09/21/2005EP1575881A2 Alanine 2,3- aminomutase
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575614A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
09/21/2005EP1575611A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy
09/21/2005EP1575574A2 Methods for treating and preventing apoptosis-related diseases using rna interfering agents
09/21/2005EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor
09/21/2005EP1575553A2 In vivo production of cyclic peptides for inhibiting protein-protein interaction
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575511A2 A new target for angiogenesis and anti-angiogenesis therapy
09/21/2005EP1575510A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575505A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
09/21/2005EP1575504A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575498A2 Antisense modulation of microsomal prostaglandin e2 synthase expression
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575483A2 Attenuated gram negative bacteria
09/21/2005EP1575481A2 Methods to increase or decrease bone density
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575354A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure
09/21/2005EP1534819A4 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
09/21/2005EP1499739A4 Methods for increasing homologous recombination of a nucleic acid sequence
09/21/2005EP1499177A4 Transgenic plants with a suppressed triterpene level
09/21/2005EP1373546A4 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof
09/21/2005EP1373297A4 A lac operator-repressor system
09/21/2005EP1313870B1 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
09/21/2005EP1294877B1 Cgi-69 compositions and methods of use
09/21/2005EP1276904A4 Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
09/21/2005EP1212082A4 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
09/21/2005EP1204740B1 Methods and compositions for directed cloning and subcloning using homologous recombination
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1104326B1 Apparatus for the delivery of drugs and genes into tissue
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1015643B1 Method and reagents for analyzing the nucleotide sequence of nucleic acids
09/21/2005EP0994954B1 T7 promoter-based expression system
09/21/2005EP0974057B1 Methods to detect hk2 polypeptides
09/21/2005EP0885310B1 Genetic markers and methods for the detection of escherichia coli serotype-0157:h7
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0804565B1 Tetracycline-regulated transcriptional modulators
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0772682B1 Modification of starch content in plants
09/21/2005EP0764205B1 Chondroitin lyase enzymes
09/21/2005EP0753057B1 Alkaline bacillus amylase
09/21/2005EP0752853B1 Human brain phosphodiesterase
09/21/2005CN2727185Y Incubation device with ice bath
09/21/2005CN1672160A Generation and selection of protein library in silico
09/21/2005CN1672052A Nano-sized optical fluorescence labels and uses thereof
09/21/2005CN1672046A Method for identifying substances
09/21/2005CN1671866A PTHrP-based prediction and diagnosis of bone disease
09/21/2005CN1671865A Microparticle based signal amplification method and its application in the detection of analytes
09/21/2005CN1671862A Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
09/21/2005CN1671851A Flavivirus vaccine delivery system
09/21/2005CN1671849A Method for enhancing the nutritive value of plant extract
1 ... 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 ... 4023